Go
MIR Clinical Specialties

Find A Location

Search

Nuclear Medicine

An asterisk* indicates that the scheduling physician or his nurse must speak to a nuclear medicine physician when scheduling the study.

ACE inhibited Renal Scintigraphy *

Best results will be obtained if all the patients angiotensin converting enzyme (ACE)-inhibitor or angiotensin receptor blocker (ARB) therapy is withheld held for 2-3 days before the examination.

Gastric Emptying Study *

No food after midnight on night before the test (if patient is diabetic, discuss with nuclear medicine physician for further instructions).

Hepatobiliary Scintigraphy *

No food for 4 hours before the examination.

MIBG Scintigraphy *

Many interfering medications and need to block thyroid gland before the test. Call for further information.

Myocardial perfusion imaging (Nuclear Medicine Stress test of the Heart)

No food after midnight on night before the test (if patient is diabetic, discuss with nuclear medicine physician for further instructions).

No caffeinated or decaffeinated beverages (including coffee, tea, hot chocolate, colas and most other soft drinks) the evening before the examination or on the morning of the examination (and it is preferable to avoid any coffee or caffeine for a full 24 hours prior to the exam).

Octreotide Scintigraphy *

It is preferable (but not essential) to discontinue treatment with Sandostatin® for 24 hours before the examination.

PET Imaging *

See PET Exam Information for Patients page.

Thyroid Scintigraphy *

Discontinue thyroid hormone pills for at least 2 weeks before the study. No iodinated contrast agents for 7-10 days before the study.

Thyroid Uptake and Treatment of Hyperthyroidism *

Discontinue propylthiouracil or methimazole at least 3 days before the appointment. No iodinated contrast agents for 3-4 weeks before the study. For women of childbearing age who have not had a tubal ligation or hysterectomy, a pregnancy test should be obtained as close as possible to the day of treatment with I-131, and preferably on the day the uptake measurement is started, prior to arrival in nuclear medicine. Patient must not be breast-feeding or recently lactating.  Unless the patient has had known longstanding Graves' disease or toxic nodular goiter, thyroid function tests (especially TSH) within 3 weeks of the scheduled appointment are recommended.

Whole Body Iodine-131 Scintigraphy *

Discontinue thyroid hormone pills for 2-3 weeks before the study, with measurement of serum TSH a few days before the examination. No iodinated contrast agents for 3-4 weeks before the study. For women of childbearing age who have not had a tubal ligation or hysterectomy, a pregnancy test should be obtained close as possible to the day of administration of I-131. Patient must not be breast-feeding or recently lactating.

Further information on our exams is available by discussion with a nuclear medicine physician at (314)362-2802, as well as in our division procedure manual.